Skip to main content
All lobbying filings

LEAVITT PARTNERS, LLC

Lobbying for SICKLE CELL DISEASE PARTNERSHIP · Alliance of patient advocates, plans, providers & manufacturers focused on federal policy.

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $20,000.00 income · posted Apr 22, 2025

Official filing document

 Lobbying activity 1
Health Issues

Advocating for federal health care policies based on the National Academies 2020 report that will improve the lives of patients living with Sickle Cell Disease.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem